Abstract
Background
Transient elastography-based liver stiffness value (TE-LSV) has been investigated for assessing clinically significant portal hypertension (CSPH). The aetiology of CSPH is an important factor determining TE-LSV. There is insufficient evidence for selecting cut-off values.
Aims
This study performed a meta-analysis to compare the three most widely used cut-off values (around 13.6 kPa, 18 kPa and 22kPa) of TE-LSV for the diagnosis of CSPH in patients with chronic viral liver disease.
Methods
The PubMed, Ovid, Web of Science and Cochrane Library databases were searched. Diagnostic data for cut-off values around 13.6 kPa, 18 kPa and 22 kPa in each included study were extracted. The bivariate model was performed to estimate pooled sensitivity, specificity, positive likelihood ratio (LR+) and negative likelihood ratio (LR-).
Results
Eleven studies assessing 910 patients were included in this meta-analysis. Pooled sensitivities of cut-off values around 13.6 kPa, 18 kPa and 22 kPa were 0.96 (95% CI 0.93–0.97), 0.85 (0.81–0.89) and 0.74 (0.66–0.80), respectively; pooled specificities were 0.60 (0.47–0.75), 0.80 (0.71-0.87) and 0.94 (0.86–0.97), respectively. Pooled LR+ values were 2.4 (1.6–3.7), 4.4 (2.9–6.8) and 11.5 (5.5–23.5) for cut-off values around 13.6 kPa, 18 kPa and 22 kPa, respectively, for pooled LR- values of 0.07 (0.04–0.13), 0.17 (0.12–0.25) and 0.28 (0.22–0.36), respectively.
Conclusion
Cut-off values around 13.6 kPa (high sensitivity) and 22 kPa (high specificity) could be used as screening and confirmation tools, respectively, in the diagnosis of CSPH. Overall, the cut-off value around 22 kPa showed the best performance.
Key Points
-
Transient elastography-based liver stiffness could be used to diagnose portal hypertension.
-
Comparison of certain cut-off values would provide more information for clinical decision-making.
-
Cut-off around 13.6 kPa was able to exclude clinically significant portal hypertension (CSPH) effectively.
-
Cut-off around 22 kPa was able to confirm CSPH effectively.
Similar content being viewed by others
Abbreviations
- BMI:
-
Body mass index
- CI:
-
Confidence interval
- CLD:
-
Chronic liver disease
- CSPH:
-
Clinically significant portal hypertension
- HSROC:
-
Hierarchical Summary Receiver Operating Characteristic
- HVPG:
-
Hepatic venous pressure gradient
- LR-:
-
Negative likelihood ratio
- LR+:
-
Positive likelihood ratio
- LSV:
-
Liver stiffness value
- TE:
-
Transient elastography
References
D’Amico G, Garcia-Tsao G, Pagliaro L (2006) Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 44(1):217–231
Bosch J (2011) Soft technique, hard end-points. J Hepatol 55(5):955–956
Castera L, Pinzani M, Bosch J (2012) Non invasive evaluation of portal hypertension using transient elastography. J Hepatol 56(3):696–703
Tsochatzis EA, Bosch J, Burroughs AK (2014) Liver cirrhosis. Lancet 383(9930):1749–1761
Targownik LE, Spiegel BM, Dulai GS, Karsan HA, Gralnek IM (2004) The cost-effectiveness of hepatic venous pressure gradient monitoring in the prevention of recurrent variceal hemorrhage. Am J Gastroenterol 99(7):1306
Pavlov CS, Casazza G, Nikolova D, Tsochatzis E, Gluud C (2016) Systematic review with meta-analysis: diagnostic accuracy of transient elastography for staging of fibrosis in people with alcoholic liver disease. Aliment Pharmacol Ther 43(5):575–585
Li Y, Huang YS, Wang ZZ et al (2016) Systematic review with meta-analysis: the diagnostic accuracy of transient elastography for the staging of liver fibrosis in patients with chronic hepatitis B. Aliment Pharmacol Ther 43(4):458–469
Dietrich CF, Bamber J, Berzigotti A et al (2017) EFSUMB guidelines and recommendations on the clinical use of liver ultrasound elastography, Update 2017 (Long Version). Ultraschall Med 38(04):377–394
Berzigotti A (2017) Non invasive evaluation of portal hypertension using ultrasound elastography. J Hepatol 67(2):399–411
Vizzutti F, Arena U, Romanelli RG et al (2007) Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. Hepatology 45(5):1290
Colecchia A, Montrone L, Scaioli E et al (2012) Measurement of spleen stiffness to evaluate portal hypertension and the presence of esophageal varices in patients with HCV-related cirrhosis. Gastroenterology 143(3):646–654
Schwabl P, Bota S, Salzl P et al (2015) New reliability criteria for transient elastography increase the number of accurate measurements for screening of cirrhosis and portal hypertension. Liver Int 35(2):381–390
Kumar A, Khan NM, Anikhindi SA et al (2017) Correlation of transient elastography with hepatic venous pressure gradient in patients with cirrhotic portal hypertension: a study of 326 patients from India. World J Gastroenterol 23(4):687–696
Nguyen-Khac E, Saint-Leger P, Tramier B, Coevoet H, Capron D, Dupas JL (2010) Noninvasive diagnosis of large esophageal varices by Fibroscan: strong influence of the cirrhosis etiology. Alcohol Clin Exp Res 34(7):1146–1153
Thiele M, Madsen BS, Hansen JF, Detlefsen S, Antonsen S, Krag A (2018) Accuracy of the enhanced liver fibrosis test vs fibrotest, elastography and indirect markers in detection of advanced fibrosis in patients with alcoholic liver disease. Gastroenterology 154(5):1369–1379
Whiting PF, Rutjes AW, Westwood ME, Mallett S et al (2011) QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155(8):529–536
Augustin S, Millán L, González A, Martell M et al (2014) Detection of early portal hypertension with routine data and liver stiffness in patients with asymptomatic liver disease: a prospective study. J Hepatol 60(3):561–569
Procopet B, Berzigotti A, Abraldes JG et al (2015) Real-time shear-wave elastography: applicability, reliability and accuracy for clinically significant portal hypertension. J Hepatol 62(5):1068–1075
Salzl P, Reiberger T, Ferlitsch M et al (2014) Evaluation of portal hypertension and varices by acoustic radiation force impulse imaging of the liver compared to transient elastography and AST to platelet ratio index. Ultraschall Med 35(6):528–533
Hametner S, Ferlitsch A, Ferlitsch M et al (2016) The VITRO score (Von Willebrand Factor Antigen/Thrombocyte Ratio) as a new marker for clinically significant portal hypertension in comparison to other non-invasive parameters of fibrosis including ELF test. PLoS One 11(2):e0149230
Hong WK, Kim MY, Baik SK et al (2013) The usefulness of non-invasive liver stiffness measurements in predicting clinically significant portal hypertension in cirrhotic patients: Korean data. Clin Mol Hepatol 19(4):370–375
Zykus R, Jonaitis L, Petrenkienė V, Pranculis A, Kupčinskas L (2015) Liver and spleen transient elastography predicts portal hypertension in patients with chronic liver disease: a prospective cohort study. BMC Gastroenterol 15:183
Reiberger T, Ferlitsch A, Payer BA et al (2012) Noninvasive screening for liver fibrosis and portal hypertension by transient elastography--a large single center experience. Wien Klin Wochenschr 124(11-12):395–402
Llop E, Berzigotti A, Reig M et al (2012) Assessment of portal hypertension by transient elastography in patients with compensated cirrhosis and potentially resectable liver tumors. J Hepatol 56(1):103–108
Bureau C, Metivier S, Peron JM et al (2008) Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease. Aliment Pharmacol Ther 27(12):1261–1268
Lemoine M, Katsahian S, Ziol M et al (2008) Liver stiffness measurement as a predictive tool of clinically significant portal hypertension in patients with compensated hepatitis C virus or alcohol-related cirrhosis. Aliment Pharmacol Ther 28(9):1102–1110
Sanchez-Conde M, Miralles P, Bellón JM et al (2011) Use of transient elastography (FibroScan(R)) for the noninvasive assessment of portal hypertension in HIV/HCV-coinfected patients. J Viral Hepat 18(10):685–691
Kitson MT, Roberts SK, Colman JC, Paul E, Button P, Kemp W (2015) Liver stiffness and the prediction of clinically significant portal hypertension and portal hypertensive complications. Scand J Gastroenterol 50(4):462–469
Franchis RD, Baveno VI Faculty (2015) Expanding consensus in portal hypertension: report of the Baveno VI consensus workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol 63(3):743
Bosch J, Abraldes JG, Berzigotti A, García-Pagan JC (2009) The clinical use of HVPG measurements in chronic liver disease. Nat Rev Gastroenterol Hepatol 6(10):573
Myers RP, Crotty P, Pomier-Layrargues G, Ma M, Urbanski SJ, Elkashab M (2010) Prevalence, risk factors and causes of discordance in fibrosis staging by transient elastography and liver biopsy. Liver Int 30(10):1471–1480
Shi K-Q, Fan YC, Pan ZZ et al (2013) Transient elastography: a meta-analysis of diagnostic accuracy in evaluation of portal hypertension in chronic liver disease. Liver Int 33(1):62–71
You MW, Kim KW, Pyo J et al (2017) A meta-analysis for the diagnostic performance of transient elastography for clinically significant portal hypertension. Ultrasound Med Biol 43(1):59–68
Kim G, Kim MY, Baik SK (2017) Transient elastography versus hepatic venous pressure gradient for diagnosing portal hypertension: a systematic review and meta-analysis. Clin Mol Hepatol 23(1):34–41
Acknowledgements
We thank C. Bureau for providing individual data in our study, and we thank all the physicians who contributed data to this study.
Funding
This study has received funding by National Natural Science Foundation, China No. 81671702 and No. 81571697.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Guarantor
The scientific guarantor of this publication is Luo Yan.
Conflict of interest
The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.
Statistics and biometry
No complex statistical methods were necessary for this paper.
Informed consent
Written informed consent was not required for this study because our study was a meta-analysis.
Ethical approval
Institutional Review Board approval was not required because our study was a meta-analysis.
Methodology
• Performed at one institution
Electronic supplementary material
ESM 1
(DOCX 327 kb)
Rights and permissions
About this article
Cite this article
Song, J., Ma, Z., Huang, J. et al. Comparison of three cut-offs to diagnose clinically significant portal hypertension by liver stiffness in chronic viral liver diseases: a meta-analysis. Eur Radiol 28, 5221–5230 (2018). https://doi.org/10.1007/s00330-018-5478-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-018-5478-z